CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -52.6% | 12,531 | -29.8% | 0.00% | – |
| Q1 2022 | $57,000 | -21.9% | 17,858 | +84.4% | 0.00% | -100.0% |
| Q2 2021 | $73,000 | -33.6% | 9,682 | -23.8% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | -63.3% | 12,701 | -66.2% | 0.00% | -75.0% |
| Q4 2020 | $300,000 | -62.4% | 37,610 | -62.4% | 0.00% | -66.7% |
| Q3 2020 | $798,000 | +26.1% | 100,095 | +56.6% | 0.01% | +9.1% |
| Q2 2020 | $633,000 | – | 63,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |